Spineguard (ALSGD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.172x

Based on the latest financial reports, Spineguard (ALSGD) has a cash flow conversion efficiency ratio of -0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-738.46K ≈ $-863.33K USD) by net assets (€4.28 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALSGD equity financing ratio to measure how much of total assets are equity-financed.

Spineguard - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Spineguard's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Spineguard cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Spineguard Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineguard ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Micronet Ltd TA:MCRNT	-0.126x
Seacera Group Bhd KLSE:7073	-0.001x
Reach Resources Ltd AU:RR1	-0.032x
Solartron Public Company Limited BK:SOLAR	-0.010x
Rail Vision Ltd. Ordinary Share NASDAQ:RVSN	-0.115x
Greenland Acquisition Corp NASDAQ:GTEC	0.118x
ReShape Lifesciences Inc NASDAQ:RSLS	-0.771x
LZ Technology Holdings Limited Class B Ordinary Shares NASDAQ:LZMH	N/A

Annual Cash Flow Conversion Efficiency for Spineguard (2011–2024)

The table below shows the annual cash flow conversion efficiency of Spineguard from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Spineguard stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€3.90 Million ≈ $4.56 Million	€-2.35 Million ≈ $-2.74 Million	-0.601x	+0.63%
2023-12-31	€6.03 Million ≈ $7.05 Million	€-3.65 Million ≈ $-4.27 Million	-0.605x	-74.67%
2022-12-31	€5.14 Million ≈ $6.01 Million	€-1.78 Million ≈ $-2.08 Million	-0.346x	-51.31%
2021-12-31	€5.05 Million ≈ $5.90 Million	€-1.16 Million ≈ $-1.35 Million	-0.229x	-100.22%
2020-12-31	€-8.93K ≈ $-10.44K	€-948.67K ≈ $-1.11 Million	106.257x	+27931.10%
2019-12-31	€592.03K ≈ $692.15K	€224.42K ≈ $262.37K	0.379x	-72.27%
2018-12-31	€-489.56K ≈ $-572.35K	€-669.26K ≈ $-782.44K	1.367x	-88.66%
2017-12-31	€-208.50K ≈ $-243.75K	€-2.51 Million ≈ $-2.94 Million	12.051x	+455.49%
2016-12-31	€1.19 Million ≈ $1.39 Million	€-4.03 Million ≈ $-4.72 Million	-3.390x	-518.39%
2015-12-31	€4.73 Million ≈ $5.54 Million	€-2.60 Million ≈ $-3.03 Million	-0.548x	+4.69%
2014-12-31	€5.77 Million ≈ $6.74 Million	€-3.32 Million ≈ $-3.88 Million	-0.575x	-71.23%
2013-12-31	€8.92 Million ≈ $10.42 Million	€-2.99 Million ≈ $-3.50 Million	-0.336x	+39.27%
2012-12-31	€5.32 Million ≈ $6.22 Million	€-2.94 Million ≈ $-3.44 Million	-0.553x	-106.39%
2011-12-31	€7.15 Million ≈ $8.36 Million	€-1.92 Million ≈ $-2.24 Million	-0.268x	--

About Spineguard

PA:ALSGD France Medical Devices

Market Cap

$9.36 Million

€8.01 Million EUR

Market Cap Rank

#27202 Global

#469 in France

Share Price

€0.09

Change (1 day)

-5.64%

52-Week Range

€0.08 - €0.19

All Time High

€5.18